Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 214,525 | 334,035 | 94,302 | 319,596 | 251,473 |
| Marketable Securities | 3,243 | 3,558 | 5,238 | 6,862 | 27,377 |
| Receivables | 1,352 | 11,650 | 300 | 900 | N/A |
| Income taxes - deferred | 2,535 | 2,053 | 377 | 2,416 | 1,437 |
| Other current assets | 6,599 | 1,200 | 1,208 | 0 | 40 |
| TOTAL | $230,047 | $355,600 | $107,697 | $332,954 | $283,957 |
| Non-Current Assets | |||||
| PPE Net | 69 | 35 | 41 | 47 | 53 |
| Investments And Advances | 0 | 0 | 0 | 3,835 | 0 |
| Intangibles | 247,116 | 223,746 | 235,677 | 0 | 0 |
| Other Non-Current Assets | 439,173 | 273,198 | 200,540 | 92,836 | 117,414 |
| TOTAL | $686,358 | $496,979 | $436,258 | $96,718 | $117,467 |
| Total Assets | $916,405 | $852,579 | $543,955 | $429,672 | $401,424 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 37,705 | 56,331 | 74,684 | 1,469 | 115 |
| TOTAL | $308,414 | $344,971 | $407,424 | $209,290 | $237,226 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 311,330 | 305,394 | 23,042 | 167,495 | 165,459 |
| TOTAL | $311,330 | $305,394 | $23,042 | $167,495 | $165,459 |
| Total Liabilities | $619,744 | $650,365 | $430,466 | $376,785 | $402,685 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 160,638 | 160,595 | 160,352 | 140,048 | 140,045 |
| Common Shares | 1,603 | 1,602 | 1,399 | 1,399 | 1,399 |
| Retained earnings | 418,746 | 326,808 | 350,151 | 289,060 | 232,834 |
| Other shareholders' equity | -3,098 | -5,185 | -4,888 | -4,049 | -1,813 |
| TOTAL | $296,661 | $202,214 | $113,489 | $52,887 | $-1,261 |
| Total Liabilities And Equity | $916,405 | $852,579 | $543,955 | $429,672 | $401,424 |